NOVEN PHARMACEUTICALS INC Contracts & Agreements
41 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (8)
- Human Resources (5)
- Intellectual Property (1)
- Mergers & Acquisitions (2)
- Uncategorized (14)
- AGREEMENT AND PLAN OF MERGER dated as of July 14, 2009, among HISAMITSU PHARMACEUTICAL CO., INC., HISAMITSU U.S., INC., NORTHSTAR MERGER SUB, INC. and NOVEN PHARMACEUTICALS, INC. (Filed With SEC on July 15, 2009)
- AMENDEDAND RESTATED EMPLOYMENTAGREEMENT (Filed With SEC on July 15, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Current Assets (Filed With SEC on November 10, 2008)
- Current Assets (Filed With SEC on November 10, 2008)
- CREDIT AGREEMENT between SUNTRUST BANK and NOVEN PHARMACEUTICALS, INC. July 31, 2008 1 CREDIT AGREEMENT Dated as of: July 31, 2008 (Filed With SEC on August 6, 2008)
- AMENDED AND RESTATED RESTRICTED STOCK AGREEMENT (Filed With SEC on June 2, 2008)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2008)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on May 5, 2008)
- STOCK APPRECIATION RIGHTS AGREEMENT (EMPLOYEE) (Filed With SEC on May 5, 2008)
- EX-10.48 Manufacturing and Supply Agreement (Filed With SEC on April 1, 2008)
- [SIGNATURE PAGE TO FOLLOW] 1 (Filed With SEC on March 21, 2008)
- SEPARATION AGREEMENT (Filed With SEC on January 3, 2008)
- RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on January 3, 2008)
- Noven Pharmaceuticals, Inc. 11960 S.W. 144th Street Miami, Florida 33186 Dated as of January 2, 2008 (Filed With SEC on January 3, 2008)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on January 3, 2008)
- EX-10.3 Asset Purchase Agreement (Filed With SEC on November 9, 2007)
- EX-10.4 Development, License and Supply Agreement (Filed With SEC on November 9, 2007)
- EX-10.5 Contract Manufacturing Agreement (Filed With SEC on November 9, 2007)
- EX-10.6 Manufacturing and Supply Agreement (Filed With SEC on November 9, 2007)
- [The remainder of this page is intentionally left blank.] 1 (Filed With SEC on August 20, 2007)
- WITNESSETH (Filed With SEC on August 20, 2007)
- EX-10.1 Letter Agreement between Shire and Noven (Filed With SEC on August 8, 2007)
- EX-10.2 Amendment dated May 3, 2007, to Letter Agreement (Filed With SEC on August 8, 2007)
- EX-10.3 Amendment dated June 4, 2007, to Letter Agreement (Filed With SEC on August 8, 2007)
- AGREEMENT AND PLAN OF MERGER among NOVEN PHARMACEUTICALS, INC., NOVEN ACQUISITION, LLC, and JDS PHARMACEUTICALS, LLC Dated as of July 9, 2007 1 TABLE OF CONTENTS (Filed With SEC on July 10, 2007)
- EX-10.1 Nonqualified Deferred Compensation Plan (Filed With SEC on November 9, 2006)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on May 23, 2006)
- Stock Appreciation Rights Agreement (Filed With SEC on May 10, 2006)
- TERMINATION AGREEMENT (Filed With SEC on March 15, 2006)
- 2006 Base Salaries for Executive Officers Name and Title Salary Robert C. Strauss President & Chief Executive Officer $ 587,741 Eduardo G. Abrao, M.D. Vice President & Chief... (Filed With SEC on December 8, 2005)
- EMPLOYMENT AGREEMENT (Change of Control) (Filed With SEC on November 18, 2005)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. The Procter & Gamble Company Health Care Research... (Filed With SEC on March 16, 2005)
- EX-10.1 Agreement dated November 5, 2003 (Filed With SEC on November 13, 2003)
- EX-10.2 Employment Agreement - Robert C. Strauss (Filed With SEC on November 13, 2003)
- EX-10.25 Trasaction Agreement (Filed With SEC on March 21, 2003)
- Amendment to Credit Agreement (Filed With SEC on May 9, 2002)
- RIGHTS AGREEMENT 121/6/01 (Filed With SEC on November 9, 2001)
